The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Goeltz Ii Robert C. since year 2005.
The trader's CIK number is 1653881.
At the time of this reporting, Goeltz Ii Robert C. is the Chief Financial Officer of Unity Biotechnology, Inc. .
(stock ticker symbol UBX).
See this page for all insider trading activities at Unity Biotechnology, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-10-10||UBX||Unity Biotechnology, Inc.||Option Ex||5,000||3.43||17,150|
|2017-05-12||CTMX||Cytomx Therapeutics, Inc.||Option Ex||19,967||5.54||110,697|
|2017-04-10||CTMX||Cytomx Therapeutics, Inc.||Option Ex||3,000||4.47||13,419|
|2017-03-20||CTMX||Cytomx Therapeutics, Inc.||Sale||21,517||19.80||426,036|
|2017-03-20||CTMX||Cytomx Therapeutics, Inc.||Option Ex||21,517||4.47||96,245|
|2017-03-09||CTMX||Cytomx Therapeutics, Inc.||Option Ex||2,500||4.47||11,182|
|2016-09-29||CTMX||Cytomx Therapeutics, Inc.||Option Ex||4,000||4.47||17,892|
|2016-05-12||CTMX||Cytomx Therapeutics, Inc.||Option Ex||2,000||4.47||8,946|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Goeltz Ii Robert C. (Chief Financial Officer of Unity Biotechnology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.